Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

OraSure Technologies InteliSwab™ COVID-19 Rapid Test Pro Visual Reference Panel
SDP

Catalog No. 23222112 Shop All OraSure Technologies Products
Change view
Click to view available options
:
InteliSwab™ COVID-19 Rapid Test Pro Visual Reference Panel
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No.
23-222-112 InteliSwab™ COVID-19 Rapid Test Pro Visual Reference Panel
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 23-222-112 Supplier OraSure Technologies Supplier No. 10010599
Only null left
Add to Cart
Add to Cart

Intended to assist new operators in becoming proficient at reading specimens with antigen levels near limit of detection of the device

  • Comprised of InteliSwab™ COVID-19 Rapid Test Pro devices that have been designed to represent reading intensities of limit of detection, low positive and negative test results
  • Kit contains:
    • Instructions for use (IFU)
    • Foil pouch with:
      • One COVID-19 limit of detection device
      • One COVID-19 low positive device
      • One COVID-19 negative device

Specifications

Certifications/Compliance FDA EUA
CE Marker No
Clia Complexity Waived
Type Visual Reference Panel
For Use With (Application) Practice reading specimens with antigen levels near the limit of detection
For Use With (Equipment) InteliSwab™ COVID-19 Rapid Test Pro
Includes Instructions for use, COVID-19 limit of detection device, COVID-19 low positive device, COVID-19 negative device
Packaging Type Kit

This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens.The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.